Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Malcolm P. Huestis"'
Publikováno v:
The Journal of Organic Chemistry. 86:6937-6942
The cross-coupling of S-aryl and S-alkyl potassium thiomethyltrifluoroborates with aryl and heteroaryl bromides is reported via photoredox/nickel dual catalysis. The transformation is achieved under mild conditions with commercially available or read
Autor:
Darlene Dela Cruz, Mark Merchant, Frances Shanahan, Christopher J. Sneeringer, Paul Gibbons, Shiva Malek, Michael Siu, Matthew R. Durk, Weiru Wang, John Moffat, Jianping Yin, Thomas Hunsaker, Liu Wendy, Dennis Leung, Ivana Yen, Charles Eigenbrot, Joachim Rudolph, Christine S Muli, Hank La, Brendan T. Parr, Antonio G. DiPasquale, Malcolm P. Huestis, Alberto Gobbi, Christine Orr
Publikováno v:
Journal of Medicinal Chemistry. 64:3940-3955
Optimization of a series of aryl urea RAF inhibitors led to the identification of type II pan-RAF inhibitor GNE-0749 (7), which features a fluoroquinazolinone hinge-binding motif. By minimizing reliance on common polar hinge contacts, this hinge bind
Autor:
Samuel Aubert-Nicol, Jean-Philippe Leclerc, Arun Yadav, Robin Larouche-Gauthier, Koilpitchai Sivamuthuraman, Malcolm P. Huestis
Publikováno v:
European Journal of Organic Chemistry. 2021:396-399
Autor:
Malcolm P, Huestis, Jack A, Terrett
Publikováno v:
Nature chemistry. 14(2)
Autor:
Ena Ladi, Matthew R. Durk, Craig Stivala, Michael Blaesse, Malcolm P. Huestis, Seth F. Harris, Daniels Blake, Christine Everett, Rajita Pappu, Stefan Steinbacher, Martin Augustin, Steven T. Staben, Michael Siu, Hans E. Purkey, Celine Eidenschenk
Publikováno v:
Journal of Medicinal Chemistry. 62:7032-7041
The pan-proteasome inhibitor bortezomib demonstrated clinical efficacy in off-label trials of Systemic Lupus Erythematosus. One potential mechanism of this clinical benefit is from the depletion of pathogenic immune cells (plasmablasts and plasmacyto
Autor:
Malcolm P, Huestis, Darlene, Dela Cruz, Antonio G, DiPasquale, Matthew R, Durk, Charles, Eigenbrot, Paul, Gibbons, Alberto, Gobbi, Thomas L, Hunsaker, Hank, La, Dennis H, Leung, Wendy, Liu, Shiva, Malek, Mark, Merchant, John G, Moffat, Christine S, Muli, Christine J, Orr, Brendan T, Parr, Frances, Shanahan, Christopher J, Sneeringer, Weiru, Wang, Ivana, Yen, Jianping, Yin, Michael, Siu, Joachim, Rudolph
Publikováno v:
Journal of medicinal chemistry. 64(7)
Optimization of a series of aryl urea RAF inhibitors led to the identification of type II pan-RAF inhibitor GNE-0749 (
Autor:
Malcolm P. Huestis
Publikováno v:
The Journal of Organic Chemistry. 81:12545-12552
The rhodium(III) catalyst tris(acetonitrile)pentamethylcyclopentadienylrhodium(III) hexafluoroantimonate ([Cp*Rh(MeCN)3](SbF6)2) reacts with 1-(2H)-phthalazinones to promote a C–H functionalization event at C8. Preparation of a set of compounds ari
Autor:
Arun Yadav, Koilpitchai Sivamuthuraman, Samuel Aubert-Nicol, Malcolm P. Huestis, Robin Larouche-Gauthier, Jean-Philippe Leclerc
Publikováno v:
European Journal of Organic Chemistry. 2021:325-325
Autor:
Liu Wendy, Danial Beaudry, Remy Angelaud, Malcolm P. Huestis, Francis Gosselin, Diane E. Carrera, Jie Xu, Michael Siu
Publikováno v:
Tetrahedron Letters. 61:152430
A practical fit-for-purpose synthesis of dual leucine zipper kinase (DLK) inhibitor GNE-834 (1) was developed. The key C C bond was constructed via a Suzuki–Miyaura cross-coupling of iodopyrazole 2 and pyridine boronic ester 3 to afford ketone 12.
Autor:
Heng Chen, Malcolm P. Huestis
Publikováno v:
ChemCatChem. 7:743-746
The development of a benzylic amine directed ortho-sulfonamidation of aryl CH bonds with sulfonyl azides was investigated. The combination of a commercially available iridium(III) complex with a silver salt gave rise to an active manifold capable of